Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/1998
12/16/1998CA2206774A1 "prionins", highly specific markers for noninvasive presymptomatic defection of tse diseases, and targets for therapeutic reagents to prevent and control tse diseases in animals and humans
12/15/1998US5849930 Pyrazolidine derivative radical scavenger brain-infarction depressant and brain-edema depressant
12/15/1998US5849924 Highly selective process for the preparation of enantiomerically pure phenyl-substituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives
12/15/1998US5849915 Buprenorphine analgesic analogues
12/15/1998US5849912 Biphenyl derivatives
12/15/1998US5849803 Method of treating erectile dysfunction with nitroglycerine
12/15/1998US5849799 Use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
12/15/1998US5849789 Use of 4-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminobenzene for the prophylaxis and treatment of reduced cerebral blood supply
12/15/1998US5849781 Tricyclic amides
12/15/1998US5849772 Carbamate compounds and processes for preparing the same
12/15/1998US5849761 Peripherally active anti-hyperalgesic opiates
12/15/1998US5849760 2-(arylalkenyl)azacycloalkane derivatives as ligands for sigma receptors
12/15/1998US5849746 Substituted 1,4-piperazine-heteroaryl derivatives as 5-HT1D receptor agonists
12/15/1998US5849745 N-benzylpiperazine compounds
12/15/1998US5849744 Pyrrolyl tetrahydrobenzoquinoxaline diones, their preparation and use as glutamate receptor antagonist
12/15/1998US5849739 5-arylindole derivatives
12/15/1998US5849710 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors
12/15/1998US5849709 Saccharopeptides and derivatives thereof
12/15/1998US5849705 Method for the treatment of Schwann cells in vivo
12/15/1998US5849691 Peptidomimetic inhibitors of cathepsin D and plasmepsins I and II
12/15/1998US5849585 Isolating and culturing Schwann cells
12/15/1998US5849556 Human growth-related CDC10 homolog
12/15/1998US5849290 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death
12/15/1998CA2163667C Imidazole lipoxygenase inhibitors
12/15/1998CA2160462C Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists
12/15/1998CA1340254C Alkylthio-alkylsulphinyl and alkylsulphonyl substituted thiophene-2-carboxamides and their use as pharmaceuticals
12/15/1998CA1340227C L-proline derivatives; process for preparing them and biological uses
12/15/1998CA1340223C 3,3-diphenylpropyl amines and pharmaceutical compositions and cholinergic uses thereof
12/15/1998CA1340205C Alkylene diamines
12/15/1998CA1340186C Peptides
12/11/1998CA2233584A1 7tm receptor hlwar77
12/11/1998CA2230998A1 Cdna clone hapoi67 that encodes a human 7-transmembrane receptor
12/10/1998WO1998055638A1 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof
12/10/1998WO1998055615A1 Apaf-1, the ced-4 human homolog, an activator of caspase-3
12/10/1998WO1998055483A1 PYRROLO[2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
12/10/1998WO1998055480A1 Substituted 1h-pyridinyl-2-ones as gabaaalpha 2/3 ligands
12/10/1998WO1998055478A1 Novel phencyclidine derivatives, preparation methods and pharmaceutical compositions containing same
12/10/1998WO1998055476A1 2-{4-[4-(4,5-dichloro-2- methylimidazol-1-yl)butyl] -1-piperazinyl}-5-fluoropyrimidine, preparation and therapeutic use
12/10/1998WO1998055474A1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application
12/10/1998WO1998055468A1 Oxazole compounds useful as pge2 agonists and antagonists
12/10/1998WO1998055132A1 Prion protein modulator factor (ppmf) and prion resistant animals
12/10/1998WO1998055115A1 Carboxamides useful as 5-ht1f agonists
12/10/1998WO1998039429A3 Compositions for treatment of disorders involving programmed cell death
12/10/1998WO1998036728A3 Sustained analgesia achieved with buprenorphine
12/10/1998WO1998035967A3 Biazacyclic crf antagonists
12/10/1998WO1998014216A3 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
12/10/1998CA2292746A1 2-{4-[4-(4,5-dichloro-2- methylimidazol-1-yl)butyl] -1-piperazinyl}-5-fluoropyrimidine, preparation and therapeutic use
12/10/1998CA2292642A1 Novel phencyclidine derivatives, preparation methods and pharmaceutical compositions containing same
12/10/1998CA2292398A1 Substituted 1h-pyridinyl-2-ones as gabaaalpha 2/3 ligands
12/10/1998CA2291624A1 Carboxamides useful as 5-ht1f agonists
12/10/1998CA2290695A1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application
12/10/1998CA2287848A1 Prion protein modulator factor (ppmf) and prion resistant animals
12/09/1998EP0882793A2 A human 7-tm receptor similar to murine frizzled-6 gene
12/09/1998EP0882791A2 WNT-11 polypeptides
12/09/1998EP0882726A1 Carbazol-carboxamides as 5-HT1F agonists
12/09/1998EP0882706A1 Cell adhesion inhibitors
12/09/1998EP0882065A2 Novel human metabotropic glutamate receptor
12/09/1998EP0882051A1 Thiophenopyrimidines
12/09/1998EP0882044A1 1,4-dihydropyridine compounds as bradykinin antagonists
12/09/1998EP0882039A1 Endothelin receptor antagonists
12/09/1998EP0422186B1 Use of oncostatin m for suppressing mhc antigens
12/09/1998CN1201461A Fused tropane-derivatives as neurotransmitter reuptake inhibitors
12/09/1998CN1201460A One pot synthesis of 2-oxazolidinone derivatives
12/09/1998CN1201454A Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
12/09/1998CN1201453A 4-(cycloalkyl) piperidine and 4-(cycloalkylalkyl) piperidine derivatives, preparation thereof and application in medicines
12/09/1998CN1201390A 5-HT3 receptor antagonists for treating dyskinesia
12/09/1998CN1201033A Solid chemical compound, preparation method therefor and use in medicine
12/09/1998CN1200924A Fluoxetine enteric micropills
12/09/1998CN1041088C Optically active imidazolizone derivative and medicinal composition for treating dementia
12/09/1998CN1041087C Arylacetamides, preparation method and use thereof
12/08/1998US5847159 1- ω-(3,4-dihydro-2-naphthalenyl)alkyl!-cyclic amine derivatives, process for preparing the same, and pharmaceutical composition containing the same
12/08/1998US5847155 Aromatic pyrrolidine amide prolyl endopeptidase inhibitors
12/08/1998US5847093 Human apoptosis regulator
12/08/1998US5847004 Method for in vivo reduction of nitric oxide levels and compositions useful therefor
12/08/1998US5846990 Substituted biphenyl isoxazole sulfonamides
12/08/1998US5846982 Inhibition of serotonin reuptake
12/08/1998US5846979 N-oxides of heterocyclic esters, amides, thioesters, and ketones
12/08/1998US5846975 Use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence
12/08/1998US5846974 Method for treating substance abuse withdrawal
12/08/1998US5846968 N-substituted azaheterocyclic carboxylic acids and esters
12/08/1998US5846965 3-aza and 3-oxa piperidone tachykinin antagonists
12/08/1998US5846939 Use of a decapeptide with benzodiazepine-type activity for preparing medicines and food supplements
12/08/1998US5846935 Modified ciliary neurotrophic factors
12/08/1998US5846810 Human 26S proteasome subunit components
12/08/1998US5846800 Nucleic acid molecules encoding a novel receptor-type protein tyrosine phosphatase-σ
12/08/1998US5846755 Method for determining the therapeutic activity of metalloproteinase inhibitor compounds
12/08/1998US5846712 Tumor suppressor gene, HIC-1
12/08/1998US5846566 Microcapsules for the controlled release of acetylsalicylic acid in the gastrointestinal environment
12/08/1998CA2150129C Amino-substituted pyrazoles having crf antagonistic activity
12/08/1998CA2073180C Therapeutic uses of melanin
12/03/1998WO1998054572A1 Methods for evaluating tissue morphogenesis and activity
12/03/1998WO1998054316A1 Sodium channel receptor
12/03/1998WO1998054222A1 Cyclic crf agonists
12/03/1998WO1998054221A1 Cyclic crf antagonist peptides
12/03/1998WO1998054213A2 Neurotrophic factor receptors
12/03/1998WO1998054189A1 Spiro-quinuclidine derivatives, their preparation and use
12/03/1998WO1998054187A1 Spiro-azacyclic derivatives and their use as therapeutic agents
12/03/1998WO1998054186A1 Salts of aromatic sulphonic acids
12/03/1998WO1998054184A1 1,6-naphthyridine anti-convulsants
12/03/1998WO1998054183A2 Ergoline derivatives and their use as somatostatin receptor antagonists
1 ... 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 ... 1833